Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Cyteir Therapeutics, Inc. (CYT) since 2021 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Cyteir Therapeutics, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1662244.
Total stock buying since 2021: $5,698,683.
Total stock sales since 2021: $3,760,757.
Total stock option exercises since 2021: $558,066.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2024 | 170,589 | $503,237 | 0 | $0 | 72,934 | $119,505 |
| 2023 | 0 | $0 | 418,277 | $1,060,757 | 180,250 | $279,162 |
| 2022 | 81,608 | $142,639 | 900,000 | $2,700,000 | 136,782 | $152,511 |
| 2021 | 282,777 | $5,052,807 | 0 | $0 | 4,100 | $6,888 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2024-03 | 170,589 | $503,237 | 0 | $0 | 8,677 | $14,663 |
| 2024-02 | 0 | $0 | 0 | $0 | 64,257 | $104,842 |
| 2023-12 | 0 | $0 | 0 | $0 | 3,993 | $6,728 |
| 2023-11 | 0 | $0 | 0 | $0 | 176,257 | $272,434 |
| 2023-07 | 0 | $0 | 140,500 | $386,377 | 0 | $0 |
| 2023-06 | 0 | $0 | 277,777 | $674,380 | 0 | $0 |
| 2022-12 | 21,202 | $27,562 | 0 | $0 | 136,782 | $152,511 |
| 2022-07 | 0 | $0 | 900,000 | $2,700,000 | 0 | $0 |
| 2022-05 | 60,406 | $115,077 | 0 | $0 | 0 | $0 |
| 2021-12 | 5,000 | $52,821 | 0 | $0 | 4,100 | $6,888 |
| 2021-06 | 277,777 | $4,999,986 | 0 | $0 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2024-03-20 | Leonard Braden Michael | Buy | 170,589 | 2.95 | 503,237 |
| 2024-03-04 | Gaiero David G (Chief Financial Officer) | Option Ex | 2,373 | 1.69 | 4,010 |
| 2024-03-04 | Renschler Markus Md (President and CEO) | Option Ex | 6,304 | 1.69 | 10,653 |
| 2024-02-29 | Gaiero David G (Chief Financial Officer) | Option Ex | 7,985 | 1.69 | 13,454 |
| 2024-02-29 | Renschler Markus Md (President and CEO) | Option Ex | 15,144 | 1.45 | 21,883 |
| 2024-02-14 | George Jean (Director) | Option Ex | 14,150 | 1.69 | 23,913 |
| 2024-02-08 | Thero John F (Director) | Option Ex | 12,828 | 1.69 | 21,679 |
| 2024-02-06 | Zakrzewski Joseph S (Director) | Option Ex | 14,150 | 1.69 | 23,913 |
| 2023-12-11 | Gaiero David G (Chief Financial Officer) | Option Ex | 3,993 | 1.69 | 6,728 |
| 2023-11-20 | Gaiero David G (Chief Financial Officer) | Option Ex | 73,940 | 1.69 | 124,588 |
| 2023-11-20 | Renschler Markus Md (President and CEO) | Option Ex | 93,477 | 1.45 | 135,073 |
| 2023-07-20 | Novo Holdings A/s (10% Owner) | Sale | 100,000 | 2.75 | 275,100 |
| 2023-07-19 | Novo Holdings A/s (10% Owner) | Sale | 1,900 | 2.76 | 5,247 |
| 2023-07-18 | Novo Holdings A/s (10% Owner) | Sale | 6,500 | 2.76 | 17,920 |
| 2023-07-17 | Novo Holdings A/s (10% Owner) | Sale | 21,100 | 2.75 | 58,003 |
| 2023-07-14 | Novo Holdings A/s (10% Owner) | Sale | 11,000 | 2.74 | 30,107 |
| 2023-06-30 | Novo Holdings A/s (10% Owner) | Sale | 200,937 | 2.63 | 529,268 |
| 2023-06-27 | Novo Holdings A/s (10% Owner) | Sale | 31,978 | 1.77 | 56,696 |
| 2023-06-26 | Novo Holdings A/s (10% Owner) | Sale | 8,437 | 1.79 | 15,110 |
| 2023-06-23 | Novo Holdings A/s (10% Owner) | Sale | 3,423 | 1.88 | 6,445 |
| 2023-06-22 | Novo Holdings A/s (10% Owner) | Sale | 5,041 | 1.94 | 9,784 |
| 2023-06-21 | Novo Holdings A/s (10% Owner) | Sale | 4,834 | 1.99 | 9,638 |
| 2023-06-20 | Novo Holdings A/s (10% Owner) | Sale | 744 | 2.12 | 1,573 |
| 2023-06-16 | Novo Holdings A/s (10% Owner) | Sale | 5,983 | 2.03 | 12,139 |
| 2023-06-15 | Novo Holdings A/s (10% Owner) | Sale | 10,002 | 2.03 | 20,304 |
| 2023-06-14 | Novo Holdings A/s (10% Owner) | Sale | 2,872 | 2.11 | 6,051 |
| 2023-06-13 | Novo Holdings A/s (10% Owner) | Sale | 2,626 | 2.10 | 5,514 |
| 2023-06-12 | Novo Holdings A/s (10% Owner) | Sale | 900 | 2.06 | 1,858 |
| 2022-12-21 | Renschler Markus Md (President and CEO) | Option Ex | 136,782 | 1.11 | 152,511 |
| 2022-12-07 | Zakrzewski Joseph S (Director) | Buy | 21,202 | 1.30 | 27,562 |
| 2022-07-20 | Novo Holdings A/s (10% Owner) | Sale | 900,000 | 3.00 | 2,700,000 |
| 2022-05-11 | Zakrzewski Joseph S (Director) | Buy | 1,000 | 1.70 | 1,700 |
| 2022-05-10 | Zakrzewski Joseph S (Director) | Buy | 49,406 | 1.89 | 93,377 |
| 2022-05-10 | Thero John F (Director) | Buy | 10,000 | 2.00 | 20,000 |
| 2021-12-28 | Zakrzewski Joseph S (Director) | Buy | 601 | 9.85 | 5,919 |
| 2021-12-27 | Zakrzewski Joseph S (Director) | Buy | 299 | 10.07 | 3,012 |
| 2021-12-23 | Zakrzewski Joseph S (Director) | Buy | 200 | 9.87 | 1,973 |
| 2021-12-20 | Gaiero David G (Chief Financial Officer) | Option Ex | 4,100 | 1.68 | 6,888 |
| 2021-12-17 | Zakrzewski Joseph S (Director) | Buy | 200 | 9.88 | 1,976 |
| 2021-12-15 | Zakrzewski Joseph S (Director) | Buy | 3,700 | 10.79 | 39,941 |
| 2021-06-22 | Naesens Janwillem (10% Owner) | Buy | 277,777 | 18.00 | 4,999,986 |
Insider trading activities including stock purchases, stock sales, and option exercises of CYT listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Cyteir Therapeutics, Inc. (symbol CYT, CIK number 1662244) see the Securities and Exchange Commission (SEC) website.